Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2011, Article ID 469127, 6 pages
http://dx.doi.org/10.1155/2011/469127
Research Article

Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy

Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town 7925, South Africa

Received 7 June 2010; Accepted 3 March 2011

Academic Editor: Ann Duerr

Copyright © 2011 Catherine Orrell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Arnsten, P. A. Demas, H. Farzadegan et al., “Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring,” Clinical Infectious Diseases, vol. 33, no. 8, pp. 1417–1423, 2001. View at Publisher · View at Google Scholar
  2. D. R. Bangsberg, F. M. Hecht, E. D. Charlebois et al., “Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population,” AIDS, vol. 14, no. 4, pp. 357–366, 2000. View at Publisher · View at Google Scholar
  3. D. L. Paterson, S. Swindells, J. Mohr et al., “Adherence to protease inhibitor therapy and outcomes in patients with HIV infection,” Annals of Internal Medicine, vol. 133, no. 1, pp. 21–30, 2000. View at Google Scholar
  4. J. B. Nachega, M. Hislop, D. W. Dowdy, R. E. Chaisson, L. Regensberg, and G. Maartens, “Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes,” Annals of Internal Medicine, vol. 146, no. 8, pp. 564–573, 2007. View at Google Scholar
  5. M. Rosenblum, S. G. Deeks, M. van der Laan, and D. R. Bangsberg, “The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy,” PLoS ONE, vol. 4, no. 9, article e7196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Oyugi, J. Byakika-Tusiime, E. D. Charlebois et al., “Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting,” Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 5, pp. 1100–1102, 2004. View at Publisher · View at Google Scholar
  7. J. B. Nachega, M. Hislop, D. W. Dowdy et al., “Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults,” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 1, pp. 78–84, 2006. View at Publisher · View at Google Scholar
  8. C. Orrell, D. R. Bangsberg, M. Badri, and R. Wood, “Adherence is not a barrier to successful antiretroviral therapy in South Africa,” AIDS, vol. 17, no. 9, pp. 1369–1375, 2003. View at Publisher · View at Google Scholar
  9. E. J. Mills, J. B. Nachega, I. Buchan et al., “Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis,” Journal of the American Medical Association, vol. 296, no. 6, pp. 679–690, 2006. View at Publisher · View at Google Scholar
  10. C. Orrell, G. Harling, S. D. Lawn et al., “Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited,” Antiviral Therapy, vol. 12, no. 1, pp. 83–88, 2007. View at Google Scholar
  11. Department of Health, 2008 National Antenatal Sentinel HIV and Syphilis Prevalence Survey, Department of Health, Eastern Cape, South Africa, 2009.
  12. South African National Antiretroviral Treatment Guidelines, National Department of Health, Eastern Cape, South Africa, 1st edition, 2004, http://www.doh.gov.za/docs/factsheets/guidelines/artguidelines04/intro.pdf.
  13. National Department of Health SA, Clinical Guidelines for the Management of HIV & AIDS in Adults and Adolescents, National Department of Health SA, 2010.
  14. R. E. Barth, M. F. S. van der Loeff, R. Schuurman, A. I. Hoepelman, and A. M. Wensing, “Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review,” The Lancet Infectious Diseases, vol. 10, no. 3, pp. 155–166, 2010. View at Publisher · View at Google Scholar
  15. M. P. Fox and S. Rosen, “Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review,” Tropical Medicine and International Health, vol. 15, supplement 1, pp. 1–15, 2010. View at Publisher · View at Google Scholar
  16. R. Kaplan, C. Orrell, E. Zwane, L.-G. Bekker, and R. Wood, “Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment,” AIDS, vol. 22, no. 13, pp. 1679–1681, 2008. View at Publisher · View at Google Scholar